Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study

Introduction: Chronic, broad-spectrum immunosuppressive therapy (IST) can be associated with side effects in many people with generalized myasthenia gravis (gMG), and treatment guidelines recommend that the IST dose be tapered once patients achieve a stable treatment response. We therefore examined...

Full description

Saved in:
Bibliographic Details
Published in:Front Neurol
Main Authors: Nowak, Richard J., Muppidi, Srikanth, Beydoun, Said R., O'Brien, Fanny L., Yountz, Marcus, Howard, James F.
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Neurology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7732596/
https://ncbi.nlm.nih.gov/pubmed/33329303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.556104
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items